Why I’m excited about Aducanumab (Aduhelm)!

Jul 30, 2021

Share Today

Spread the word.

Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval…and it’s probably not what you think! A quick, but useful listen.

In this Episode You Will Learn:

  • The terms of the approval of the drug
  • What Aducanumab was able to accomplish in Alzheimer’s patients
  • The circumstances that led to Aducanumab being approved
  • Some of the problems that arise with Aducanumab
  • Why I am excited about Aducanumab


Stay up-to-date with the latest episodes!


Share Today

Spread the word.


Submit a Comment

Your email address will not be published. Required fields are marked *